NEW YORK (GenomeWeb News) – Contract research organization AI Biotech announced it has received a 30-month, $4.3 million contract to carry out a next-generation sequencing project.
The work being carried out is classified and company President and CSO Robert Harris declined to provide specifics about the project to GenomeWeb Daily News, saying only that it is broad-based and will involve the sequencing of "many individual human genomes." The goal is to develop genomic information and methods of handling and processing the data.
He said is he is not allowed to identify the US government agency that awarded AI Biotech the contract.
AI Biotech is based in Richmond, Va., and provides research services, drug development, assay development, and clinical testing services to life science organizations.